Finding a Cure for Brain Tumors Through Advocacy and Public Policy
Eliminating brain tumors means finding a cure for all tumor types, including ependymoma. To achieve this,
David Arons, Chief Executive Officer of the National Brain Tumor Society (NBTS) and its Chief Public Policy and Advocacy Officer, is helping give the brain tumor community a voice.
“We are too small of a community to not be connected,” says Arons. “And we need to be heard because more federal research funding needs to go to brain tumor research.”
Head to the Hill impacts research funding
Since 2012, the NBTS has joined other disease organizations, like the CERN Foundation, at an event called
Head to the Hill in Washington, D.C., to advocate to Congress.
“The federal government is the largest funder of biomedical research related to brain tumors,” says Arons. “So we need to encourage congress and the Administration to increase cancer research dollars.” And he believes their efforts have made an impact.
The overall amount of National Cancer Institute (NCI) funding for brain tumor research has increased from an estimated $140 million in 2012 to an estimated $170 million in 2017, according to Arons.
The Department of Defense (DOD) spending on brain-tumor related research has also increased. “A few years ago, pediatric and adult brain tumor researchers were applying for DOD funding from a pool of about $12 million. Now, that pool is $30 million,” says Arons.